Quick Answer
Neuronetics, Inc. reported Operating Income Loss of -$31.44 million for the year ending 2025.
- Neuronetics, Inc. showed an increase of +9.0% in Operating Income Loss from 2024 to 2025.
- This data is from Neuronetics, Inc.'s annual report (Form 10-K), filed with the SEC on March 17, 2026.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2017: -$3.99 million | Q2 2017: -$2.58 million | Q3 2017: -$2.81 million | Q4 2017: -$4.23 million | Q1 2018: -$4.61 million | Q2 2018: -$5.24 million | Q3 2018: -$4.33 million | Q4 2018: -$5.66 million | Q1 2019: -$7.06 million | Q2 2019: -$6.61 million | Q3 2019: -$6.33 million | Q4 2019: -$6.94 million | Q1 2020: -$10.37 million | Q2 2020: -$6.86 million | Q3 2020: -$2.42 million | Q4 2020: -$2.66 million | Q1 2021: -$6.91 million | Q2 2021: -$6.56 million | Q3 2021: -$7.18 million | Q1 2022: -$10.14 million | Q2 2022: -$9.80 million | Q3 2022: -$7.45 million | Q1 2023: -$9.91 million | Q2 2023: -$7.35 million | Q3 2023: -$8.87 million | Q1 2024: -$6.86 million | Q2 2024: -$8.51 million | Q3 2024: -$7.73 million | Q1 2025: -$11.01 million | Q2 2025: -$8.06 million | Q3 2025: -$7.32 million.
- Over the full 10 years of available data (2016 to 2025), Neuronetics, Inc.'s Operating Income Loss has declined by 236.7%.
- Historical annual values: Fiscal year 2025: -$31.44 million | Fiscal year 2024: -$34.56 million | Fiscal year 2023: -$30.55 million | Fiscal year 2022: -$35.11 million | Fiscal year 2021: -$27.56 million | Fiscal year 2020: -$22.31 million | Fiscal year 2019: -$26.93 million | Fiscal year 2018: -$19.83 million | Fiscal year 2017: -$13.61 million | Fiscal year 2016: -$9.34 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: